Obesity Clinical Trial
Official title:
A Pilot Study to Assess the Impact of Exposure to Popular Media Content on Patients Living With Obesity
| NCT number | NCT05001633 |
| Other study ID # | 135462 |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 9, 2021 |
| Est. completion date | December 31, 2022 |
This study will explore the impact of exposure to popular media content on patients living with obesity. Findings from this study will provide new insights that will extend current understanding of exposure to media portrayal. This is a proof of principle pilot study that will evaluate the feasibility of recruitment, randomisation, assessment procedures and implementation of the intervention with the aim to facilitate the planning and the conduct of a full-scale randomised controlled trial.
| Status | Recruiting |
| Enrollment | 20 |
| Est. completion date | December 31, 2022 |
| Est. primary completion date | December 31, 2022 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: 1. Female adults aged 18-65 years. 2. Body Mass Index equal or greater than 30 kg/m2. 3. Weight stable at time of recruitment, defined as less than 5% variation in body weight over the preceding 3 months. 4. Proficient in written and spoken English. 5. Able to comply with study protocol. 6. Willing and able to provide written informed consent. Exclusion Criteria: 1. Type 1 and type 2 diabetes (in view of altered circulated gut hormone profiles and gustatory function). 2. Smoking (in view of the fact that smoking affects salivary cortisol). 3. Diagnosed with uncontrolled severe depression. 4. Diagnosed with uncontrolled psychiatric disorder. 5. Previous bariatric surgery. 6. Acute illness or chronic conditions that may impact HPA including Cushing syndrome. 7. Known or suspected history of HIV, Hepatitis B or C or other blood-borne diseases (in view of safety regulations regarding exposure to blood products). 8. Currently using glucocorticoids. 9. Pregnancy or lactation. 10. Elevated self-perceived stress as assessed by the Perceived Stress Scale. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | University College London Hospital | London |
| Lead Sponsor | Collaborator |
|---|---|
| University College, London |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Cortisol levels | To characterise the effect of a modified media content upon cortisol secretion in people living with obesity. | up to 4 hours | |
| Secondary | heart rate | To characterise the impact of a modified media content on heart rate | up to 4 hours | |
| Secondary | systolic and diastolic blood pressure | To characterise the impact of a modified media content on blood pressure | up to 4 hours | |
| Secondary | blood glucose | To characterise the impact of a modified media content on blood glucose | up to 4 hours | |
| Secondary | salivary hormones | To characterise the impact of a modified media content on salivary hormones - what hormones will be analysed will depend on the availability of assays and will be decided later on at the end of the study | up to 4 hours | |
| Secondary | inflammatory cytokines | To characterise the impact of a modified media content on inflammatory cytokines - what cytokines will be analysed will depend on the availability of assays and will be decided later on at the end of the study | up to 4 hours | |
| Secondary | dietary intake | To characterise the impact of a modified media content on dietary intake through the use of an online recalling diary called Intake24 | up to 4 hours | |
| Secondary | experience | To evaluate participants' experience through semi-structure interviews | up to 4 hours |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |